Vidal scores 10 in 1

Publishing 10 papers in one year is difficult for most scientists.

Written byMaria Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Publishing 10 papers in one year is difficult for most scientists. But try publishing all 10 in a single journal issue, as Harvard Medical School geneticist Marc Vidal recently did: His name appeared on 10 articles in a recent special issue of Genome Research (vol. 14, issue 10b, October 2004).

Vidal says he didn't contribute text to all the papers. "I read all of them, that's for sure!" laughs Vidal, also at the Dana-Farber Cancer Institute in Boston. He did personally write the opening Perspective: "ORFeome Cloning and Systems Biology: Standardized Mass Production of the Parts from the Parts-List." David Hill, a postdoc in his lab, wrote an accompanying Outlook: "Academia-Industry Collaboration: An Integral Element for Building 'Omic' Resources." Vidal's other bylines included two letters highlighting work from his lab and two papers describing research methods. Four papers discussing resources in the field also listed him as a contributing author.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies